03969nam 22006735 450 991025413540332120200704094518.03-319-33438-710.1007/978-3-319-33438-7(CKB)3710000000685992(EBL)4530827(DE-He213)978-3-319-33438-7(MiAaPQ)EBC4530827(PPN)194078000(EXLCZ)99371000000068599220160521d2016 u| 0engur|n|---|||||txtrdacontentcrdamediacrrdacarrierEarth Science Satellite Applications Current and Future Prospects /edited by Faisal Hossain1st ed. 2016.Cham :Springer International Publishing :Imprint: Springer,2016.1 online resource (287 p.)Springer Remote Sensing/Photogrammetry,2198-0721Description based upon print version of record.3-319-33436-0 Includes bibliographical references at the end of each chapters.Introduction: Many Eyes in the Sky and Compound Eye -- Overview of current and future satellite missions for societal applications -- How is more eyes better than one eye? -- Theme: Water and Disaster Management -- Africa -- Asia -- South America -- Europe -- Issues and the Path Forward -- Theme: Agricultural Management -- Africa -- Asia -- South America -- Europe -- Issues and the Path Forward -- Theme: Energy and Carbon Management -- Africa -- Asia -- South America -- Europe -- Issues and the Path Forward -- Theme: Health and Eco-logical Forecasting -- Africa -- Asia -- South America -- Europe -- Issues and the Path Forward -- CLOSURE Chapter.The combined observational power of the multiple earth observing satellites is currently not being harnessed holistically to produce more durable societal benefits. We are not able to take complete advantage of the prolific amount of scientific output and remote sensing data that are emerging rapidly from satellite missions and convert them quickly into decision-making products for users. The current application framework we have appears to be an analog one lacking the absorption bandwidth required to handle scientific research and the voluminous (petabyte-scale) satellite data. This book will tackle this question: "How do we change this course and take full advantage of satellite observational capability for a more sustainable, happier and safer future in the coming decades?".Springer Remote Sensing/Photogrammetry,2198-0721Remote sensingAerospace engineeringAstronauticsPhysical geographyInformation theoryRemote Sensing/Photogrammetryhttps://scigraph.springernature.com/ontologies/product-market-codes/J13010Aerospace Technology and Astronauticshttps://scigraph.springernature.com/ontologies/product-market-codes/T17050Earth System Scienceshttps://scigraph.springernature.com/ontologies/product-market-codes/G35000Information and Communication, Circuitshttps://scigraph.springernature.com/ontologies/product-market-codes/M13038Remote sensing.Aerospace engineering.Astronautics.Physical geography.Information theory.Remote Sensing/Photogrammetry.Aerospace Technology and Astronautics.Earth System Sciences.Information and Communication, Circuits.550.28Hossain Faisaledthttp://id.loc.gov/vocabulary/relators/edtMiAaPQMiAaPQMiAaPQBOOK9910254135403321Earth Science Satellite Applications2545341UNINA05345nam 2200673Ia 450 991102035880332120200520144314.09786611939397978128193939512819393909780470696873047069687797804706968800470696885(CKB)1000000000552962(EBL)366784(OCoLC)437234398(SSID)ssj0000225840(PQKBManifestationID)11202225(PQKBTitleCode)TC0000225840(PQKBWorkID)10234196(PQKB)11672332(MiAaPQ)EBC366784(Perlego)2766177(EXLCZ)99100000000055296220080604d2008 uy 0engur|n|---|||||txtccrPractical lipid management concepts and controversies /Peter P. Toth, Kevin C. MakiChichester, West Sussex, UK ;Hoboken, NJ Wiley-Blackwell20081 online resource (264 p.)Description based upon print version of record.9780470056905 0470056908 Includes bibliographical references and index.Practical Lipid Management; Contents; Foreword; Preface; Acknowledgements; Chapter 1 Epidemiology of Lipids, Lipid Management and Risk for Coronary Heart Disease: An Overview; 1.1 Early History of Cardiovascular Epidemiology; 1.2 Lipid Risk Factors are Central to Efforts at CHD Prevention; 1.3 LDL-C and CHD Risk; 1.4 LDL-C Lowering and CHD Risk Reduction; 1.5 Other Atherogenic Lipoproteins: Atherogenic Remnants; 1.6 HDL-C and CHD Risk; 1.7 Trends in Lipids and Lipid Management in the USA1.8 The National Cholesterol Education Program Evaluation Project Using Novel E-Technology (NEPTUNE) II SurveyControversy: Should a Measure of Atherogenic Lipoprotein Particle Number be used in Risk Assessment And/Or to Evaluate the Response to Lipid Therapy?; Chapter 2 Vascular Biology and Atherogenesis; 2.1 Introduction; 2.2 Arterial Structure; 2.3 Endothelial Cell Function and Dysfunction; 2.4 The Role of Monocytes and Lymphocytes; 2.5 Atheromatous Plaques; Chapter 3 Detection, Evaluation, and Treatment Goals for Lipid Disorders in Adults3.1 Matching Aggressiveness of Treatment to Absolute Risk3.2 Screening for Dyslipidemias; 3.3 Risk Stratification; 3.4 Steps in the Risk Stratification Process - Major Risk Categories; 3.5 Tips for Calculating the Framingham Risk Score; 3.6 Subcategories for Consideration of More Aggressive Optional Treatment Goals; 3.7 Very High Risk Patients, Optional LDL-C Goal <70 mg dl-1; 3.8 Moderately High Risk Patients, OPTIONAL LDL-C Goal <100 mg dl-1; 3.9 Treatment Goals for Patients with Elevated Triglycerides; 3.10 Triglycerides and HDL-C as Targets for TherapyControversy: Should Treatment Guidelines Include Targets for the Total/HDL Cholesterol Ratio?Chapter 4 Therapeutic Lifestyle Changes in the Management of Lipid Disorders and the Metabolic Syndrome; 4.1 Nature and Nurture in the Development of CHD Risk Factors; 4.2 Lifestyle Factors as Determinants of CHD Risk in Populations; 4.3 Within Country Variations in Lifestyle and CHD Risk; 4.4 The Metabolic Syndrome; 4.5 Therapeutic Lifestyle Changes; 4.6 The TLC Diet; 4.7 Dietary Adjuncts: Viscous Fibers and Plant Sterol/Stanol Products; 4.8 Physical Activity and Weight Reduction4.9 Smoking Cessation4.10 Importance of Allied Health Professionals; Chapter 5 Management of Elevated Low-Density Lipoprotein Cholesterol; 5.1 Relationship between LDL-C and Risk for Cardiovascular Events; 5.2 Clinical Trial Support for Very Aggressive LDL-C Reduction for Those at Highest Risk; 5.3 Genetic Disorders Associated with Elevated LDL-C; 5.4 Atherogenic Impact of LDL-C; 5.5 Management of Elevated LDL-C; 5.6 Summary; Controversy: How Low Should We Go?; Controversy: Risks and Bene.ts of High-Dose Statin Therapy Versus Combination Lipid Drug TherapyControversy: Do the Benefits of Low-Density Lipoprotein Cholesterol Reduction Depend Strictly on "How Low You Go" or also on "How You Get There"?Lipid management is a key part of medical practice, affecting the prevention and treatment of several diseases, including diabetes, cardiovascular disease and stroke. A practical text on the clinical management of dyslipidemias, Practical Lipid Management balances conceptual development and pathophysiology with a straightforward approach to the identification and treatment of abnormalities in lipid metabolism. The book explores the role of novel risk markers in clinical practice, summarizes the current guidelines for lipid management, and offers a critical and systematic approach to iHyperlipidemiaTreatmentCoronary heart diseasePreventionHyperlipidemiaTreatment.Coronary heart diseasePrevention.616.3/997Toth Peter P1343554Maki Kevin C1729521MiAaPQMiAaPQMiAaPQBOOK9911020358803321Practical lipid management4421581UNINA